Researchers at the University of Michigan believe they are closer to a breakthrough that could potentially help more than ...
A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for treating cognitive symptoms in Parkinson’s disease, a condition currently ...
A ketogenic diet supplement could improve CAR T cell function, offering a potential boost to cancer therapy, according to new ...
Research out of Roswell Park Comprehensive Cancer Center has shed light on how the drug venetoclax (brand name Venclexta) works synergistically with CAR T-cell immunotherapy to combat chronic ...
A simple dietary supplement in ketogenic diet can boost ‘CAR T’ cell function — a personalised treatment that reprogrammes ...
Long COVID's impact on the brain explored through spike protein presence, immune response, and potential treatment pathways.
You might think they’re unnecessary, because so many people have had their tonsils removed—but tonsils actually serve an ...
Kite, a Gilead Company (Nasdaq: GILD), today announced findings from three new analyses for Yescarta® (axicabtagene ciloleucel) that demonstrate improved outcomes for people living with relapsed or ...
This article delves into the potential research implications of the Vilon peptide, examining how it might be employed in ...
Based on these observations Molecular Partners is amending the protocol of this study to further optimize the dosing schedule and improve the exposure profile of MP0533 in subsequent dosing cohorts.
Johnson & Johnson today announced new frontline data featuring TECVAYLI® (teclistamab-cqyv) from two investigational studies in patients with newly diagnosed multiple myeloma (NDMM) in induction and ...